Showing results (1231-1240 of 2,267) with videos related to
Sort By:
Pageof 227
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|April 21, 2026
Interleukin-23 Inhibitors in Inflammatory Bowel DiseasePierluigi Puca, Simone Parello, Stefania Colantuono, et al.European Review for Medical and Pharmacological Sciences|October 25, 2019
Cannabis-induced acute pancreatitis: a case report with comprehensive literature reviewD Pagliari, A Saviano, M G Brizi, et al.Digestion|February 3, 2004
Probiotic treatment increases salivary counts of lactobacilli: a double-blind, randomized, controlled studyM Montalto, M Vastola, L Marigo, et al.European Review for Medical and Pharmacological Sciences|October 11, 2019
Akkermansia muciniphila: key player in metabolic and gastrointestinal disordersI G Macchione, L R Lopetuso, G Ianiro, et al.Vaccines|February 26, 2022
Vaccines, Microbiota and Immunonutrition: Food for ThoughtLaura Di Renzo, Laura Franza, Diego Monsignore, et al.British Journal of Cancer|November 1, 1995
The effect of family size on estimates of the frequency of hereditary non-polyposis colorectal cancerA Percesepe, M Anti, L Roncucci, et al.Journal of Clinical Gastroenterology|April 1, 1996
Role of dental plaque in the transmission of Helicobacter pylori infectionG Cammarota, A Tursi, M Montalto, et al.British Journal of Rheumatology|January 1, 1997
Leucocytoclastic vasculitis associated with hepatitis C virus antibodiesR Manna, L Todaro, M Latteri, et al.Expert Opinion on Pharmacotherapy|September 8, 2016
High prevalence of constipation and reduced quality of life in opioid-dependent patients treated with opioid substitution treatmentsFabio Lugoboni, Antonio Mirijello, Lorenzo Zamboni, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 1, 2008
Second-line levofloxacin-based triple schemes for Helicobacter pylori eradicationS Di Caro, F Franceschi, A Mariani, et al.Pageof 227